| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Valproic Acid | FAERS: 3 | US FAERS | |
| 3 | Metronidazole | FAERS: 2 | US FAERS | |
| 4 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 5 | tofacitinib | FAERS: 2 | US FAERS | |
| 6 | Atorvastatin | FAERS: 1 | US FAERS | |
| 7 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 8 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 9 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 10 | Thyroxine | FAERS: 1 | US FAERS | |
| 11 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 12 | exemestane | FAERS: 1 | US FAERS | |
| 13 | nelarabine | FAERS: 1 | US FAERS | |
| 14 | Vincristine | SIDER | ||
| 15 | ixabepilone | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.